FDA NDC Directory · JSON-LD · Markdown

Duetact

NDC 64764-304 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namepioglitazone and glimepiride
Labeler / ManufacturerTakeda Pharmaceuticals America, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021925
Dosage form / routeTABLET · ORAL
Active ingredientsGLIMEPIRIDE (4 mg/1)
PIOGLITAZONE HYDROCHLORIDE (30 mg/1)
Marketing started20060728
Package count2

External sources

Source: openFDA. Public-domain (CC0).